Multiple drug therapy--a comparative study with 2 tier and 3 tier combination of rifampicin, clofazimine, DDS, INAH and thiacetazone in lepromatous cases.

Kundu Sk, Sonali Chaudhury(Northwestern University), Subrata Ghosh(University College Cork), Subrata Hazra

PubMed

April 1, 1981

Cited by 1

Related Papers

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

|New England Journal of Medicine|2016|1.8k

Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

|New England Journal of Medicine|2012|1.1k

European evidence-based Consensus on the management of ulcerative colitis: Current management

|Journal of Crohn s and Colitis|2008|558

Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease

|Gastroenterology|2018|253

Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients

|Transplantation and Cellular Therapy|2013|248